MedPath

tility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of pancreatic tumors: a prospective multicenter study

Not Applicable
Conditions
Pancreatic tumors
Registration Number
JPRN-UMIN000011124
Lead Sponsor
Study Group for Contrast-enhanced Harmonic Endoscopic Ultrasonography
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
240
Inclusion Criteria

Not provided

Exclusion Criteria

Inapropriate to perform endoscopic ultrasonography Impossible to perform endoscopy Surgically altered digestive tract Failure of other organs (ASA: Grade 3, 4) Allergy to iodine or eggs Renal failure Inability to obtain informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To measure the diagnostic ability of contrast-enhanced harmonic endoscopic ultrasonography in diagnosing pancreatic tumors. To compare the diagnostic accuracy of contrast-enhanced harmonic endoscopic ultrasonography with that of tissue harmonic endoscopic ultrasonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath